Home / Biopharma / Healthcare Stocks Taking Toll on Investment Valuation: AbbVie Inc. (NYSE:ABBV), Novartis AG (NYSE:NVS)

Healthcare Stocks Taking Toll on Investment Valuation: AbbVie Inc. (NYSE:ABBV), Novartis AG (NYSE:NVS)

Waking on tracing line of previous stocks, AbbVie Inc. (NYSE:ABBV) also making a luring appeal, share price swings at $63.34 with percentage change of -1.15% in most recent trading session. The firm attains price to earnings ratio of 18.16 and its current ratio stands at 1.80. The price to current year EPS has 185.20%. To see more absolute value, taking notice on its price to next year’s EPS that cloud be 17.71%, according to Thomson Reuter. The co has dividend yield of 3.60% that is also considered as effective indicator. To see the ratio analysis, the debt to equity ratio appeared as 6.71 for seeing its liquidity position.

The BOD of AbbVie Inc. (ABBV) reported a quarterly cash dividend of $0.57 per share. The cash dividend is payable Nov. 15, 2016 to stockholders of record at the close of business on Oct. 14, 2016. Since the firm’s inception in 2013, AbbVie has surged its dividend by over 42 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have yearlyly surged their dividend for at least 25 consecutive years.

Always volatility measures make charm for active trader; price volatility of stock was 1.65% for a week and 1.48% for a month. The price volatility’s Average True Range for 14 days was 0.99. On these bases, analysts would recommend this stock as an “Active Spinning Stocks.” ABBV’s institutional ownership was registered as 71.90% while insider ownership was 0.10%. The firm attains analyst recommendation of 2.30 on scale of 1-5 with week’s performance of -1.97%.

Following previous ticker characteristics, Novartis AG (NYSE:NVS) also run on active notice, stock price moved down -1.44% after traded at $79.12 in most recent trading session.

NVS has price to earnings ratio of 28.61 and the price to current year EPS stands at -33.30%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 7.15%. The earning yield also gives right direction to lure investment, as the co has 3.44% dividend yield. Moving toward ratio analysis, it has current ratio of 0.90 and quick ratio was calculated as 0.60. The debt to equity ratio appeared as 0.36 for seeing its liquidity position.

Taking notice on volatility measures, price volatility of stock was 1.13% for a week and 1.05% for a month. The price volatility’s Average True Range for 14 days was 1.01. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.40 out of 1-5 scale with week’s performance of -1.29%. NVS’s institutional ownership was registered as 10.10%, while insider ownership was 9.30%.

 

About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Check Also

Stocks Faring Away From Broker’s Choice: Opko Health (NASDAQ:OPK), Shire plc (NASDAQ:SHPG)

Several matter pinch shares of Opko Health, Inc. (NASDAQ:OPK) [Trend Analysis], as shares plunging -2.56% …

Leave a Reply

Your email address will not be published. Required fields are marked *